These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 18291106)
1. Detection of filamentous tau inclusions by the fluorescent Congo red derivative FSB [(trans,trans)-1-fluoro-2,5-bis(3-hydroxycarbonyl-4-hydroxy)styrylbenzene]. Velasco A; Fraser G; Delobel P; Ghetti B; Lavenir I; Goedert M FEBS Lett; 2008 Mar; 582(6):901-6. PubMed ID: 18291106 [TBL] [Abstract][Full Text] [Related]
2. A comparison of amyloid fibrillogenesis using the novel fluorescent compound K114. Crystal AS; Giasson BI; Crowe A; Kung MP; Zhuang ZP; Trojanowski JQ; Lee VM J Neurochem; 2003 Sep; 86(6):1359-68. PubMed ID: 12950445 [TBL] [Abstract][Full Text] [Related]
3. Fluoro-substituted and 13C-labeled styrylbenzene derivatives for detecting brain amyloid plaques. Sato K; Higuchi M; Iwata N; Saido TC; Sasamoto K Eur J Med Chem; 2004 Jul; 39(7):573-8. PubMed ID: 15236837 [TBL] [Abstract][Full Text] [Related]
4. The Congo red derivative FSB binds to curli amyloid fibers and specifically stains curliated E. coli. Reichhardt C; Cegelski L PLoS One; 2018; 13(8):e0203226. PubMed ID: 30161215 [TBL] [Abstract][Full Text] [Related]
5. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2,5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. Schmidt ML; Schuck T; Sheridan S; Kung MP; Kung H; Zhuang ZP; Bergeron C; Lamarche JS; Skovronsky D; Giasson BI; Lee VM; Trojanowski JQ Am J Pathol; 2001 Sep; 159(3):937-43. PubMed ID: 11549586 [TBL] [Abstract][Full Text] [Related]
6. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease. Lee VM; Trojanowski JQ Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147 [TBL] [Abstract][Full Text] [Related]
7. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Ishihara T; Zhang B; Higuchi M; Yoshiyama Y; Trojanowski JQ; Lee VM Am J Pathol; 2001 Feb; 158(2):555-62. PubMed ID: 11159192 [TBL] [Abstract][Full Text] [Related]
8. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Goedert M Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313 [TBL] [Abstract][Full Text] [Related]
9. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Gasparini L; Crowther RA; Martin KR; Berg N; Coleman M; Goedert M; Spillantini MG Neurobiol Aging; 2011 Mar; 32(3):419-33. PubMed ID: 19356824 [TBL] [Abstract][Full Text] [Related]
10. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. Allen B; Ingram E; Takao M; Smith MJ; Jakes R; Virdee K; Yoshida H; Holzer M; Craxton M; Emson PC; Atzori C; Migheli A; Crowther RA; Ghetti B; Spillantini MG; Goedert M J Neurosci; 2002 Nov; 22(21):9340-51. PubMed ID: 12417659 [TBL] [Abstract][Full Text] [Related]
11. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies. Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611 [TBL] [Abstract][Full Text] [Related]
12. Ordered Assembly of Tau Protein and Neurodegeneration. Goedert M; Spillantini MG Adv Exp Med Biol; 2019; 1184():3-21. PubMed ID: 32096024 [TBL] [Abstract][Full Text] [Related]
13. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Clavaguera F; Akatsu H; Fraser G; Crowther RA; Frank S; Hench J; Probst A; Winkler DT; Reichwald J; Staufenbiel M; Ghetti B; Goedert M; Tolnay M Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9535-40. PubMed ID: 23690619 [TBL] [Abstract][Full Text] [Related]
14. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord. Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267 [TBL] [Abstract][Full Text] [Related]
15. Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Ishihara T; Hong M; Zhang B; Nakagawa Y; Lee MK; Trojanowski JQ; Lee VM Neuron; 1999 Nov; 24(3):751-62. PubMed ID: 10595524 [TBL] [Abstract][Full Text] [Related]
16. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy. Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937 [TBL] [Abstract][Full Text] [Related]
18. In Vivo Imaging of Tau Aggregates in the Mouse Retina. Schön C; Herms J Methods Mol Biol; 2017; 1523():361-368. PubMed ID: 27975264 [TBL] [Abstract][Full Text] [Related]
19. Analysis of tauopathies with transgenic mice. Hutton M; Lewis J; Dickson D; Yen SH; McGowan E Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522 [TBL] [Abstract][Full Text] [Related]
20. Effects of alpha-tocopherol on an animal model of tauopathies. Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]